世界の水痘生ワクチン市場レポート2020年

QYResearchが発行した調査報告書(QYR20ST05241)
◆英語タイトル:Global Varicella Live Vaccine Sales Market Report 2020
◆商品コード:QYR20ST05241
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年9月(※2024年版があります。お問い合わせください。)
◆ページ数:132
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、北米、ヨーロッパ、日本、アジアなど
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の水痘生ワクチン市場について種類別(一価水痘ワクチン、水痘ワクチン)、用途別(水痘予防接種、帯状疱疹予防接種、はしか、おたふく風邪、風疹および水痘(MMRV)予防接種)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・水痘生ワクチン市場の概要
・世界の主要地域別水痘生ワクチン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の水痘生ワクチン市場規模2015-2026:種類別(一価水痘ワクチン、水痘ワクチン)
・世界の水痘生ワクチン市場規模2015-2026:用途別(水痘予防接種、帯状疱疹予防接種、はしか、おたふく風邪、風疹および水痘(MMRV)予防接種)
・水痘生ワクチンの北米市場規模2015-2020
・水痘生ワクチンのヨーロッパ市場規模2015-2020
・水痘生ワクチンの中国市場規模2015-2020
・水痘生ワクチンの日本市場規模2015-2020
・水痘生ワクチンの東南アジア市場規模2015-2020
・水痘生ワクチンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・水痘生ワクチンの製造コスト分析
・販売チャネル、流通業者、顧客
・水痘生ワクチンの市場動向・機会・課題
・調査の結論
【レポートの概要】

A recently published report by QY Research titled Global Varicella Live Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Varicella Live Vaccine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Varicella zoster is also known as Human alphaherpesvirus 3 and causes chicken pox and herpes zoster in humans. The infection caused by this virus can be prevented by the use of vaccinations that are specially formulated to provide immunity against the virus. There are mainly two types of vaccinations available to provide immunity against varicella zoster such as monovalent varicella vaccine and combination varicella vaccine.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Varicella Live Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Varicella Live Vaccine industry.
Based on our recent survey, we have several different scenarios about the Varicella Live Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2361 million in 2019. The market size of Varicella Live Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Varicella Live Vaccine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Varicella Live Vaccine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Varicella Live Vaccine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Varicella Live Vaccine market. The report also includes nautical information, where it shows Varicella Live Vaccine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Varicella Live Vaccine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Varicella Live Vaccine market.
Geographical Analysis:
Based on region, the global Varicella Live Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Varicella Live Vaccine market are
Bio-Med Pvt. Limited
Changchun BCHT Biotechnology
Emcure Pharmaceuticals
GlaxoSmithKline
GC Pharma
Merck & Co. Inc.
Mitsubishi Tanabe Pharma
Novo Medi Sciences
Sanofi
Takeda Pharmaceutical Company Limited.
Segment by Type
Monovalent Varicella Vaccine
Combination Varicella Vaccine
Segment by Application
Chickenpox Immunization
Herpes Zoster Immunization
Measles, Mumps, Rubella and Varicella (MMRV) Immunization
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Varicella Live Vaccine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Varicella Live Vaccine market.
• The market share of the global Varicella Live Vaccine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Varicella Live Vaccine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Varicella Live Vaccine market.

【レポートの目次】

1 Varicella Live Vaccine Market Overview
1.1 Varicella Live Vaccine Product Scope
1.2 Varicella Live Vaccine Segment by Type
1.2.1 Global Varicella Live Vaccine Sales by Type (2020-2026)
1.2.2 Monovalent Varicella Vaccine
1.2.3 Combination Varicella Vaccine
1.3 Varicella Live Vaccine Segment by Application
1.3.1 Global Varicella Live Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Chickenpox Immunization
1.3.3 Herpes Zoster Immunization
1.3.4 Measles, Mumps, Rubella and Varicella (MMRV) Immunization
1.4 Varicella Live Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Varicella Live Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Varicella Live Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Varicella Live Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Varicella Live Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Varicella Live Vaccine Industry
1.5.1.1 Varicella Live Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Varicella Live Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Varicella Live Vaccine Players to Combat Covid-19 Impact

2 Varicella Live Vaccine Estimate and Forecast by Region
2.1 Global Varicella Live Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Varicella Live Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Varicella Live Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Varicella Live Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Varicella Live Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Varicella Live Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Varicella Live Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.3 China Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.6 India Varicella Live Vaccine Estimates and Projections (2015-2026)
3 Global Varicella Live Vaccine Competition Landscape by Players
3.1 Global Top Varicella Live Vaccine Players by Sales (2015-2020)
3.2 Global Top Varicella Live Vaccine Players by Revenue (2015-2020)
3.3 Global Varicella Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Live Vaccine as of 2019)
3.4 Global Varicella Live Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Varicella Live Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Varicella Live Vaccine Players (Opinion Leaders)
4 Global Varicella Live Vaccine Market Size by Type
4.1 Global Varicella Live Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Varicella Live Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Varicella Live Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Varicella Live Vaccine Price by Type (2014-2020)
4.2 Global Varicella Live Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Varicella Live Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Varicella Live Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Varicella Live Vaccine Price Forecast by Type (2021-2026)
5 Global Varicella Live Vaccine Market Size by Application
5.1 Global Varicella Live Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Varicella Live Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Varicella Live Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Varicella Live Vaccine Price by Application (2015-2020)
5.2 Global Varicella Live Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Varicella Live Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Varicella Live Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Varicella Live Vaccine Price Forecast by Application (2021-2026)

3 North America Varicella Live Vaccine Market Facts & Figures
3.2 North America Varicella Live Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Varicella Live Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Varicella Live Vaccine Sales Market Share by Application (2015-2020)

4 Europe Varicella Live Vaccine Market Facts & Figures
4.2 Europe Varicella Live Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Varicella Live Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Varicella Live Vaccine Sales Market Share by Application (2015-2020)

5 China Varicella Live Vaccine Market Facts & Figures
5.2 China Varicella Live Vaccine Sales Market Share by Company (2015-2020)
5.3 China Varicella Live Vaccine Sales Market Share by Type (2015-2020)
5.4 China Varicella Live Vaccine Sales Market Share by Application (2015-2020)

6 Japan Varicella Live Vaccine Market Facts & Figures
6.2 Japan Varicella Live Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Varicella Live Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Varicella Live Vaccine Sales Market Share by Application (2015-2020)

7 Southeast Asia Varicella Live Vaccine Market Facts & Figures
7.2 Southeast Asia Varicella Live Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Varicella Live Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Varicella Live Vaccine Sales Market Share by Application (2015-2020)

8 India Varicella Live Vaccine Market Facts & Figures
8.2 India Varicella Live Vaccine Sales Market Share by Company (2015-2020)
8.3 India Varicella Live Vaccine Sales Market Share by Type (2015-2020)
8.4 India Varicella Live Vaccine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Varicella Live Vaccine Business
12.1 Bio-Med Pvt. Limited
12.1.1 Bio-Med Pvt. Limited Varicella Live Vaccine Corporation Information
12.1.2 Bio-Med Pvt. Limited Varicella Live Vaccine Business Overview and Total Revenue
12.1.3 Bio-Med Pvt. Limited Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bio-Med Pvt. Limited Varicella Live Vaccine Products Offered
12.1.5 Bio-Med Pvt. Limited Recent Development
12.2 Changchun BCHT Biotechnology
12.2.1 Changchun BCHT Biotechnology Varicella Live Vaccine Corporation Information
12.2.2 Changchun BCHT Biotechnology Varicella Live Vaccine Business Overview and Total Revenue
12.2.3 Changchun BCHT Biotechnology Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Changchun BCHT Biotechnology Varicella Live Vaccine Products Offered
12.2.5 Changchun BCHT Biotechnology Recent Development
12.3 Emcure Pharmaceuticals
12.3.1 Emcure Pharmaceuticals Varicella Live Vaccine Corporation Information
12.3.2 Emcure Pharmaceuticals Varicella Live Vaccine Business Overview and Total Revenue
12.3.3 Emcure Pharmaceuticals Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Emcure Pharmaceuticals Varicella Live Vaccine Products Offered
12.3.5 Emcure Pharmaceuticals Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Varicella Live Vaccine Corporation Information
12.4.2 GlaxoSmithKline Varicella Live Vaccine Business Overview and Total Revenue
12.4.3 GlaxoSmithKline Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline Varicella Live Vaccine Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 GC Pharma
12.5.1 GC Pharma Varicella Live Vaccine Corporation Information
12.5.2 GC Pharma Varicella Live Vaccine Business Overview and Total Revenue
12.5.3 GC Pharma Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GC Pharma Varicella Live Vaccine Products Offered
12.5.5 GC Pharma Recent Development
12.6 Merck & Co. Inc.
12.6.1 Merck & Co. Inc. Varicella Live Vaccine Corporation Information
12.6.2 Merck & Co. Inc. Varicella Live Vaccine Business Overview and Total Revenue
12.6.3 Merck & Co. Inc. Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck & Co. Inc. Varicella Live Vaccine Products Offered
12.6.5 Merck & Co. Inc. Recent Development
12.7 Mitsubishi Tanabe Pharma
12.7.1 Mitsubishi Tanabe Pharma Varicella Live Vaccine Corporation Information
12.7.2 Mitsubishi Tanabe Pharma Varicella Live Vaccine Business Overview and Total Revenue
12.7.3 Mitsubishi Tanabe Pharma Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Mitsubishi Tanabe Pharma Varicella Live Vaccine Products Offered
12.7.5 Mitsubishi Tanabe Pharma Recent Development
12.8 Novo Medi Sciences
12.8.1 Novo Medi Sciences Varicella Live Vaccine Corporation Information
12.8.2 Novo Medi Sciences Varicella Live Vaccine Business Overview and Total Revenue
12.8.3 Novo Medi Sciences Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Novo Medi Sciences Varicella Live Vaccine Products Offered
12.8.5 Novo Medi Sciences Recent Development
12.9 Sanofi
12.9.1 Sanofi Varicella Live Vaccine Corporation Information
12.9.2 Sanofi Varicella Live Vaccine Business Overview and Total Revenue
12.9.3 Sanofi Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sanofi Varicella Live Vaccine Products Offered
12.9.5 Sanofi Recent Development
12.10 Takeda Pharmaceutical Company Limited.
12.10.1 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Corporation Information
12.10.2 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Business Overview and Total Revenue
12.10.3 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Products Offered
12.10.5 Takeda Pharmaceutical Company Limited. Recent Development

13 Varicella Live Vaccine Manufacturing Cost Analysis
13.1 Varicella Live Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Varicella Live Vaccine
13.4 Varicella Live Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Varicella Live Vaccine Distributors List
14.3 Varicella Live Vaccine Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の水痘生ワクチン市場レポート2020年(Global Varicella Live Vaccine Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。